Catalent
CTLT
#1815
Rank
NZ$20.60 B
Marketcap
NZ$113.51
Share price
0.00%
Change (1 day)
14.49%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): NZ-$2.09

According to Catalent's latest financial reports the company's current EPS (TTM) is NZ-$11.32. In 2022 the company made an earnings per share (EPS) of NZ$4.06 a decrease over its 2021 EPS that were of NZ$5.85.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.09-151.38%
2022NZ$4.06-30.58%
2021NZ$5.8579.67%
2020NZ$3.25114.12%
2019NZ$1.52-15%
2018NZ$1.7975.44%
2017NZ$1.02-22.97%
2016NZ$1.32-59.56%
2015NZ$3.27282.05%
2014NZ$0.86-378.2%
2013NZ-$0.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$3.43-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$27.27-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ-$1.34-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
NZ-$2.65-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA